title: Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.
abstract: Epidemiological studies indicate that women have a higher risk of Alzheimer's disease (AD) even after adjustment for age. Though transgenic mouse models of AD develop AD-related amyloid beta (Abeta) and/or tau pathology, gender differences have not been well documented in these models. In this study, we found that female 3xTg-AD transgenic mice expressing mutant APP, presenilin-1 and tau have significantly more aggressive Abeta pathology. We also found an increase in beta-secretase activity and a reduction of neprilysin in female mice compared to males; this suggests that a combination of increased Abeta production and decreased Abeta degradation may contribute to higher risk of AD in females. In contrast to significantly more aggressive Abeta pathology in females, gender did not affect the levels of phosphorylated tau in 3xTg-AD mice. These results point to the involvement of Abeta pathways in the higher risk of AD in women. In addition to comparison of pathology between genders at 9, 16 and 23 months of age, we examined the progression of Abeta pathology at additional age points; i.e., brain Abeta load, intraneuronal oligomeric Abeta distribution and plaque load, in male 3xTg-AD mice at 3, 6, 9, 12, 16, 20 and 23 months of age. These findings confirm progressive Abeta pathology in 3xTg-AD transgenic mice, and provide guidance for their use in therapeutic research.
authors.affiliation: Department of Neurology, Georgetown University Medical Center, Washington, DC 20057, USA.
authors.forename: Chiho
authors.initials: C
authors.lastname: Hirata-Fukae
authors.forename: Hui-Fang
authors.initials: HF
authors.lastname: Li
authors.forename: Hyang-Sook
authors.initials: HS
authors.lastname: Hoe
authors.forename: Audrey J
authors.initials: AJ
authors.lastname: Gray
authors.forename: S Sakura
authors.initials: SS
authors.lastname: Minami
authors.forename: Katsuyoshi
authors.initials: K
authors.lastname: Hamada
authors.forename: Takako
authors.initials: T
authors.lastname: Niikura
authors.forename: Fang
authors.initials: F
authors.lastname: Hua
authors.forename: Hiroe
authors.initials: H
authors.lastname: Tsukagoshi-Nagai
authors.forename: Yuko
authors.initials: Y
authors.lastname: Horikoshi-Sakuraba
authors.forename: Mohamed
authors.initials: M
authors.lastname: Mughal
authors.forename: G William
authors.initials: GW
authors.lastname: Rebeck
authors.forename: Frank M
authors.initials: FM
authors.lastname: LaFerla
authors.forename: Mark P
authors.initials: MP
authors.lastname: Mattson
authors.forename: Nobuhisa
authors.initials: N
authors.lastname: Iwata
authors.forename: Takaomi C
authors.initials: TC
authors.lastname: Saido
authors.forename: William L
authors.initials: WL
authors.lastname: Klein
authors.forename: Karen E
authors.initials: KE
authors.lastname: Duff
authors.forename: Paul S
authors.initials: PS
authors.lastname: Aisen
authors.forename: Yasuji
authors.initials: Y
authors.lastname: Matsuoka
mesh_terms: D000367:Age Factors; D000544:Alzheimer Disease / Q000378:metabolism / Q000473:pathology*; D053829:Amyloid Precursor Protein Secretases / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000378:metabolism / Q000473:pathology*; D005260:Female; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D053764:Presenilin-1 / Q000378:metabolism; D012727:Sex Characteristics; D013045:Species Specificity; D016875:tau Proteins / Q000378:metabolism*
chemical_list: D016229:Amyloid beta-Peptides; D053764:Presenilin-1; D016875:tau Proteins; D053829:Amyloid Precursor Protein Secretases